These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 15067328)

  • 21. Aberrant nuclear localization and gene mutation of beta-catenin in low-grade adenocarcinoma of fetal lung type: up-regulation of the Wnt signaling pathway may be a common denominator for the development of tumors that form morules.
    Nakatani Y; Masudo K; Miyagi Y; Inayama Y; Kawano N; Tanaka Y; Kato K; Ito T; Kitamura H; Nagashima Y; Yamanaka S; Nakamura N; Sano J; Ogawa N; Ishiwa N; Notohara K; Resl M; Mark EJ
    Mod Pathol; 2002 Jun; 15(6):617-24. PubMed ID: 12065775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aberrant expression and function of TCF4 in the proliferation of hepatocellular carcinoma cell line BEL-7402.
    Zhao DH; Hong JJ; Guo SY; Yang RL; Yuan J; Wen CY; Zhou KY; Li CJ
    Cell Res; 2004 Feb; 14(1):74-80. PubMed ID: 15040893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EBP50, a beta-catenin-associating protein, enhances Wnt signaling and is over-expressed in hepatocellular carcinoma.
    Shibata T; Chuma M; Kokubu A; Sakamoto M; Hirohashi S
    Hepatology; 2003 Jul; 38(1):178-86. PubMed ID: 12830000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated expression of axin2 and hnkd mRNA provides evidence that Wnt/beta -catenin signaling is activated in human colon tumors.
    Yan D; Wiesmann M; Rohan M; Chan V; Jefferson AB; Guo L; Sakamoto D; Caothien RH; Fuller JH; Reinhard C; Garcia PD; Randazzo FM; Escobedo J; Fantl WJ; Williams LT
    Proc Natl Acad Sci U S A; 2001 Dec; 98(26):14973-8. PubMed ID: 11752446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta-catenin accumulation in the progression of human hepatocarcinogenesis correlates with loss of E-cadherin and accumulation of p53, but not with expression of conventional WNT-1 target genes.
    Prange W; Breuhahn K; Fischer F; Zilkens C; Pietsch T; Petmecky K; Eilers R; Dienes HP; Schirmacher P
    J Pathol; 2003 Oct; 201(2):250-9. PubMed ID: 14517842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beta-catenin mutations in hepatocellular carcinoma correlate with a low rate of loss of heterozygosity.
    Legoix P; Bluteau O; Bayer J; Perret C; Balabaud C; Belghiti J; Franco D; Thomas G; Laurent-Puig P; Zucman-Rossi J
    Oncogene; 1999 Jul; 18(27):4044-6. PubMed ID: 10435629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concomitant activation of Wnt pathway and loss of mismatch repair function in human melanoma.
    Castiglia D; Bernardini S; Alvino E; Pagani E; De Luca N; Falcinelli S; Pacchiarotti A; Bonmassar E; Zambruno G; D'Atri S
    Genes Chromosomes Cancer; 2008 Jul; 47(7):614-24. PubMed ID: 18384130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overview of the molecular biology of hepatocellular neoplasms and hepatoblastomas of the mouse liver.
    Kim Y; Sills RC; Houle CD
    Toxicol Pathol; 2005; 33(1):175-80. PubMed ID: 15805069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nuclear accumulation of beta-catenin without an additional somatic mutation in coding region of the APC gene in hepatoblastoma from a familial adenomatous polyposis patient.
    Inukai T; Furuuchi K; Sugita K; Uno K; Ooi A; Sasaki F; Hamada J; Moriuchi T; Nakazawa S
    Oncol Rep; 2004 Jan; 11(1):121-6. PubMed ID: 14654913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutational activation of the RAS-RAF-MAPK and the Wnt pathway in small intestinal adenocarcinomas.
    Bläker H; Helmchen B; Bönisch A; Aulmann S; Penzel R; Otto HF; Rieker RJ
    Scand J Gastroenterol; 2004 Aug; 39(8):748-53. PubMed ID: 15513360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. P53 mutation as a source of aberrant beta-catenin accumulation in cancer cells.
    Cagatay T; Ozturk M
    Oncogene; 2002 Nov; 21(52):7971-80. PubMed ID: 12439747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. APC mutations are infrequent but present in human lung cancer.
    Ohgaki H; Kros JM; Okamoto Y; Gaspert A; Huang H; Kurrer MO
    Cancer Lett; 2004 Apr; 207(2):197-203. PubMed ID: 15072829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic and epigenetic alterations of the APC gene in malignant melanoma.
    Worm J; Christensen C; Grønbaek K; Tulchinsky E; Guldberg P
    Oncogene; 2004 Jul; 23(30):5215-26. PubMed ID: 15133491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accumulation of beta-catenin protein and mutations in exon 3 of beta-catenin gene in gastrointestinal carcinoid tumor.
    Fujimori M; Ikeda S; Shimizu Y; Okajima M; Asahara T
    Cancer Res; 2001 Sep; 61(18):6656-9. PubMed ID: 11559529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel colon cancer cell lines leading to better understanding of the diversity of respective primary cancers.
    Vécsey-Semjén B; Becker KF; Sinski A; Blennow E; Vietor I; Zatloukal K; Beug H; Wagner E; Huber LA
    Oncogene; 2002 Jul; 21(30):4646-62. PubMed ID: 12096341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of orphan G-protein-coupled receptor, Gpr49, in human hepatocellular carcinomas with beta-catenin mutations.
    Yamamoto Y; Sakamoto M; Fujii G; Tsuiji H; Kenetaka K; Asaka M; Hirohashi S
    Hepatology; 2003 Mar; 37(3):528-33. PubMed ID: 12601349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Wnt-signaling pathway is not implicated in tumorigenesis of Merkel cell carcinoma.
    Liu S; Daa T; Kashima K; Kondoh Y; Yokoyama S
    J Cutan Pathol; 2007 Jan; 34(1):22-6. PubMed ID: 17214850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cadherin/catenin complex appears to be intact in hepatocellular carcinomas from Australia and South Africa.
    Herath NI; Walsh MD; Kew MC; Young J; Leggett BA; Macdonald GA
    J Gastroenterol Hepatol; 2004 Jun; 19(6):676-82. PubMed ID: 15151624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors.
    Tissier F; Cavard C; Groussin L; Perlemoine K; Fumey G; Hagneré AM; René-Corail F; Jullian E; Gicquel C; Bertagna X; Vacher-Lavenu MC; Perret C; Bertherat J
    Cancer Res; 2005 Sep; 65(17):7622-7. PubMed ID: 16140927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colorectal cancer and genetic alterations in the Wnt pathway.
    Segditsas S; Tomlinson I
    Oncogene; 2006 Dec; 25(57):7531-7. PubMed ID: 17143297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.